Answers are grounded in this paper and cite their sources.
A narrative review highlights challenges in using medical marijuana for cancer pain, suggesting areas for future research.
Overall, there continues to be limited evidence to support the use of medical cannabis for treatment of cancer-related pain. While significant progress has been made in this domain of pain management research, current federal regulations classifying marijuana as a Schedule I substance continue to limit large research studies. As the legal landscape evolves, an emphasis on future randomized controlled trial studies focused on the challenges related to medical marijuana dosing, side effects, and long-term safety will help advance the field and future cancer patients.
No takes yet. Share an insight, caveat, or question.
Mendelson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: